Zacks Investment Research on MSN

Wall Street analysts see a 50.86% upside in NovoCure (NVCR): Can the stock really move this high?

Shares of NovoCure (NVCR) have gained 18.1% over the past four weeks to close the last trading session at $17.99, but there could still be a solid upside left in the stock if short-term price targets ...
Zacks Investment Research on MSN

Wall Street analysts think TFI International (TFII) could surge 28.97%: Read this before placing a bet

TFI International Inc. (TFII) closed the last trading session at $136.26, gaining 1.5% over the past four weeks, but there ...